306 related articles for article (PubMed ID: 23078283)
1. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
[TBL] [Abstract][Full Text] [Related]
2. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.
Morley JF; Duda JE
J Parkinsons Dis; 2014; 4(2):169-73. PubMed ID: 24284418
[TBL] [Abstract][Full Text] [Related]
3. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
Hausner RS
J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced parkinsonism in the elderly.
Stephen PJ; Williamson J
Lancet; 1984 Nov; 2(8411):1082-3. PubMed ID: 6150149
[TBL] [Abstract][Full Text] [Related]
7. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.
Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M
Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229
[TBL] [Abstract][Full Text] [Related]
8. Cinnarizine-induced parkinsonism: ten years later.
Martí-Massó JF; Poza JJ
Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
[TBL] [Abstract][Full Text] [Related]
9. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
[TBL] [Abstract][Full Text] [Related]
10. A severe and irreversible case of tardive rigid-akinetic parkinsonian syndrome: the role of the DaTscan.
Politis AM; Kokras N; Pappa D; Siarkos C; Katirtzoglou E; Papadimitriou GN; Kahn DA
J Psychiatr Pract; 2013 Sep; 19(5):413-8. PubMed ID: 24042248
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced Parkinson`s disease. A clinical review.
Bohlega SA; Al-Foghom NB
Neurosciences (Riyadh); 2013 Jul; 18(3):215-21. PubMed ID: 23887211
[TBL] [Abstract][Full Text] [Related]
12. Drug induced parkinsonism: a common cause of parkinsonism in older people.
Thanvi B; Treadwell S
Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
[TBL] [Abstract][Full Text] [Related]
13. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
14. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
Oh YS; Kwon DY; Kim JS; Park MH; Berg D
Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
[TBL] [Abstract][Full Text] [Related]
15. Clozapine withdrawal symptoms in a Parkinson's disease patient.
Zesiewicz TA; Borra S; Hauser RA
Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
[TBL] [Abstract][Full Text] [Related]
16. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
Yomtoob J; Koloms K; Bega D
Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
[TBL] [Abstract][Full Text] [Related]
17. Failure of recognition of drug-induced parkinsonism in the elderly.
Esper CD; Factor SA
Mov Disord; 2008 Feb; 23(3):401-4. PubMed ID: 18067180
[TBL] [Abstract][Full Text] [Related]
18. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
Binder RL; Jonelis FJ
Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced parkinsonism].
Kuzuhara S
Nihon Rinsho; 1997 Jan; 55(1):112-7. PubMed ID: 9014432
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]